The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients
Judith Hurley(University of Miami), Mark D. Pegram(Stanford University), Carmen Gomez‐Fernandez(University of Miami), José Pablo Leone(Harvard University), Steven E. Rodgers(University of Miami), Isildinha M. Reis(University of Miami), Rene Larrieu(The University of Texas at San Antonio Health Science Center), Jean L. Wright(University of North Carolina at Chapel Hill)
Cited by 87
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
|Practical Radiation Oncology|2018|615
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Effectiveness of early orthodontic treatment with the twin-block appliance: A multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|374